(Methylsulfonyl)(2-Piperazinylphenyl)Amine → 8-{1-(2-Methylsulfonylaminophenyl)piperazin-4-yl}-2-phenylpurine
반응식
[CH3:1][S:2]([NH:5][C:6]1[CH:11]=[CH:10][CH:9]=[CH:8][C:7]=1[N:12]1[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1)(=[O:4])=[O:3].Cl[C:19]1[NH:27][C:26]2[C:21](=[N:22][C:23]([C:28]3[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=3)=[N:24][CH:25]=2)[N:20]=1>>[CH3:1][S:2]([NH:5][C:6]1[CH:11]=[CH:10][CH:9]=[CH:8][C:7]=1[N:12]1[CH2:17][CH2:16][N:15]([C:19]2[NH:27][C:26]3[C:21](=[N:22][C:23]([C:28]4[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=4)=[N:24][CH:25]=3)[N:20]=2)[CH2:14][CH2:13]1)(=[O:3])=[O:4]참가 물질
3
실험 절차
By following the same reaction as described in Example 19 except that 1-(2-methylsulfonylaminophenyl)piperazine was used in place of 3-tert-butoxycarbonyl-cis-3,7-diazabicyclo[3.3.0]octane, and 8-chloro-2-phenylpurine was used in place of 2-chloro-5-phenylbenzimidazole, the title compound was prepared.
후처리
- customthe same reaction
출처 및 근거
- ORD 기록
- ord-44dcce2e172448c0ad3ca7fb98b021c5